Jay Lichter's Net Worth

$158 Million

Estimate Recalculated Mar 6, 2024 04:20PM EST

Who is Jay Lichter?

Jay Lichter has an estimated net worth of $158 Million. This is based on reported shares across multiple companies, which include Janux Therapeutics, Inc., Synthorx, Inc., ARATANA THERAPEUTICS, INC., OTONOMY, INC., and AKESIS PHARMACEUTICALS, INC..

SEC CIK

Jay Lichter's CIK is 0001376355

Past Insider Trading and Trends

2014 was Jay Lichter's most active year for acquiring shares with 17 total transactions. Jay Lichter's most active month to acquire stocks was the month of May. 2014 was Jay Lichter's most active year for disposing of shares, totalling 19 transactions. Jay Lichter's most active month to dispose stocks was the month of July. 2021 saw Jay Lichter paying a total of $10,699,987.00 for 8,722,059 shares, this is the most they've acquired in one year. In 2020 Jay Lichter cashed out on 6,924,784 shares for a total of $157,647,030.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Janux Therapeutics, Inc. (JANX) Snapshot price: $8.88

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
849.85K
$5.87
$4,988,642.98
849.85K
Nov 13
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 14
Form 4
+4,514.47%
8.67M
$17.00
—
8.87M
Jun 15
Form 4
—
0
—
—
0
Jun 10
Form 3
—
0
—
—
0
No matching records found

Synthorx, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.28M
$68.00
-$155,084,404.00
0
Jan 23
Form 4
-87.40%
-4.15M
—
—
598.57K
Jan 14
Form 4
—
0
—
—
0
Jun 7
Form 4
+3,334.62%
6.24M
$11.00
—
6.43M
Dec 11
Form 4
—
0
—
—
0
Dec 6
Form 3
—
0
—
—
0
No matching records found

ARATANA THERAPEUTICS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-29.89%
-1.00M
—
—
2.35M
Jul 15
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Jun 19
Form 4
-19.78%
-825.00K
$19.00
-$15,675,000.00
3.35M
Feb 3
Form 4/A
+13.62%
500K
$6.00
$3,000,000.00
4.17M
Jul 2
Form 4
+1,455.78%
3.43M
—
—
3.67M
Jul 2
Form 4
—
0
—
—
0
Jun 26
Form 3
—
0
—
—
0
No matching records found

OTONOMY, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 22
Form 4
-100.00%
-321.18K
$2.70
-$866,543.64
0
Mar 3
Form 4
-73.57%
-893.83K
$2.87
-$2,560,930.05
321.18K
Feb 26 - Mar 2
Form 4
-47.11%
-1.08M
$2.95
-$3,193,662.76
1.22M
Feb 23 - Feb 25
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 19
Form 4
+1.42%
32.21K
$16.27
$637.93
2.3M
Aug 31
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 19
Form 4
+106.28%
2.26M
$14.20
$1,749,970.69
4.38M
Aug 18
Form 3
—
0
—
—
0
No matching records found

AKESIS PHARMACEUTICALS, INC. No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 15 - Jun 13
Form 4
—
0
—
—
0
Oct 2
Form 3
—
0
—
—
0
No matching records found